Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim SirketifiledCriticalNeutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16199ApriorityCriticalpatent/TR201716199A1/tr
Publication of TR201716199A1publicationCriticalpatent/TR201716199A1/tr
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Mevcut buluş astım ve KOAH (Kronik Obstrüktif Akciğer Hastalığı) tedavisinde kullanılacak arformoterol ve ipratropium içeren farmasötik bileşimlere ilişkindir.
TR2017/16199A2017-10-202017-10-20Arformoterol ve ipratropium içeren yeni farmasötik bileşimler.
TR201716199A1
(tr)
Compuestos derivados de indazol, inhibidores de janus quinasa (jak); composicion farmaceutica que los comprende; y su uso para tratar rinitis alergica, congestion nasal, asma, bronquitis cronica, artritis, insuficiencia cardiaca, colitis ulcerativa, infeccion viral y bacteriana, cancer y alzheimer, entre otras enfermedades.
Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma.